▮ Entertainment

Top Stories
Slide Shows
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ More

Wall Street Events

Plus

Neg

Email

NVIDIA Q3 21 Earnings Conference Call At 5:00 PM ET

By RTTNews Staff Writer ✉ | Published: 11/18/2020 6:00 AM ET

NVIDIA Corporation (NVDA) will host a conference call at 5:00 PM ET on November 18, 2020, to discuss Q3 21 earnings results.

To access the live webcast, log on to http://www.nvidia.com

For comments and feedback contact: editorial@rttnews.com

PDUFA Biotech stocks Chemotherapy COVID19 vaccines heart failure lupus ARS

Biotech Stocks Facing FDA Decision In January 2021

New Drugs Approved In November

New Drugs Approved In November

PDUFA 2020 Multiple Sclerosis Cystic Fibrosis Edema PAH Sleep wake disorder hereditary angioedema attacks

Biotech Stocks Facing FDA Decision In December 2020

Latest Updates on COVID-19

COVID-19 Deaths Up By At Least 10% In 25 US States

Johnson & Johnson's Covid-19 Vaccine Safe, Well-tolerated

Switzerland Authorizes Moderna's COVID-19 Vaccine

Vir, GSK In Deal With NHS-Supported AGILE To Evaluate VIR-7832 In Early Treatment Of COVID-19

COVID Hospitalizations Dropping In US For 4th Straight Day

Read More

COVID-19: Drugs in Development

RELATED NEWS

U.K Competition Regulator To Investigate Nvidia's $40 Bln Acquisition Of Arm

NVIDIA Corporation Q3 adjusted earnings Beat Estimates

NVIDIA Q3 21 Earnings Conference Call At 5:00 PM ET

Follow RTT

Editor's Pick
Most Read
Most Emailed

GE Sues Siemens Energy For Allegedly Stealing Gas-Turbine Trade Secrets

Cigarette Health Warnings Effective Date Postponed

JPMorgan Chase & Co Q4 Profit Tops Estimates; Managed Net Revenue Up 3%

Scalpa Numb Maximum Strength Topical Anesthetic Cream Being Recalled

WOOF! Petco Soars In First Day Trading

US' NHTSA Asks Tesla To Recall 158000 Vehicles

Restaurant Trends In 2021

Travelers To U.S Required To Show Evidence Of Negative COVID-19 Test: American Airlines

Sea To Summit Recalls Camping Pots For Burn, Scald Risks

Johnson & Johnson's Covid-19 Vaccine Safe, Well-tolerated

CES 2021 To Feature More Than 1900 Exhibitors

CVS Health To Facilitate Cancer Treatment At Home

Pre-market Movers In Healthcare Sector: TTOO, TMBR, HAPP, PSTI, GOVX, AVGR...

Stock Alert: Marinus Pharmaceuticals Climbs 11%

Stock Alert: La Jolla Pharmaceutical Soars On Deal With PAION

Roche: Updated Data Confirms Tecentriq With Avastin Substantially Improves Overall Survival In HCC

Pre-market Movers In Healthcare Sector: TRXC, JAGX, ALRN, BNGO, MBRX, APDN…

Will Aurinia Pharma's Lupus Nephritis Drug Pass FDA Muster?

Johnson & Johnson's Covid-19 Vaccine Safe, Well-tolerated

IPO Lockup Expiration Alert: Berkeley Lights (BLI)

US' NHTSA Asks Tesla To Recall 158000 Vehicles

IPO Lockup Expiration Alert: Pandion Therapeutics (PAND)

Stock Alert: Lemonade Rises 8%

Pre-market Movers In Healthcare Sector: DBVT, OBSV, APYX...

40 North Raises Takeover Bid For W.R. Grace To $65 Per Share - Quick Facts

Intercontinental Exchange Announces Business Combination Of Bakkt & VIH - Quick Facts

Eli Lilly: FDA Accepts Supplemental New Drug Application For Jardiance - Quick Facts

Crocs Lifts FY20 Revenue Outlook; Sees Accelerated FY21 Revenue Growth Of 20% To 25%

Eligo, GSK Sign Deal To Advance Eligobiotics For Treatment/prevention Of Acne Vulgaris

Bristol Myers Board Authorizes Incremental Share Repurchase - Quick Facts

Build-A-Bear Workshop Sees Lower Revenue, EBIT In Q4 - Quick Facts

Lilly's Donanemab Slows Clinical Decline Of Alzheimer's Disease In Phase 2 Trial

GIP Reaches Agreement To Buy Signature Aviation For About $4.63 Bln

Capita Signs GBP 1 Bln Worth Royal Navy Training Services Contract

JD Sports Fashion 22-week Revenue Up; Sees FY Headline Pre-tax Profit Ahead Of Market

NeuroRx, Relief, Quantum Leap To Include ZYESAMI In I-SPY COVID-19 Trial